GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Forian Inc (NAS:FORA) » Definitions » Insider Ownership

Forian (Forian) Insider Ownership : 20.62 % (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Forian Insider Ownership?

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Forian's insider ownership is 20.62%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Forian's Institutional Ownership is 4.66%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Forian's Float Percentage Of Total Shares Outstanding is 63.83%.


Forian Insider Ownership Historical Data

The historical data trend for Forian's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forian Insider Ownership Chart

Forian Historical Data

The historical data trend for Forian can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Insider Ownership 18.69 18.69 19.66 19.66 19.66 20.79 20.76 20.63 20.63 20.62

Forian Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.


Forian (Forian) Business Description

Traded in Other Exchanges
N/A
Address
41 University Drive, Suite 400, Newtown, PA, USA, 18940
Forian Inc provides a suite of SaaS solutions, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments, as well as cannabis dispensaries, manufacturers, cultivators, and regulators.
Executives
Martin J Wygod director P.O. BOX 676306, RANCHO SANTA FE CA 92067
Trotman Stanley S Jr director
Max C Wygod director, officer: Executive Chairman 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Max Wygod Family Dynasty Trust 10 percent owner 41 UNIVERSITY DRIVE, SUITE 400, NEWTOWN PA 18940
Michael Vesey officer: Chief Financial Officer 4041-T HADLEY ROAD, S. PLAINFIELD NJ 07080
Jennifer Hajj director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Kristiina Md Vuori director C/O WEBMD HEALTH CORP., 111 EIGHTH AVENUE, NEW YORK NY 10011
Scott Matthew Ogur director C/O HELIX TCS, INC., 10200 E. GIRARD AVENUE, SUITE B420, DENVER CO 80231
Farren Clifford A Jr officer: Chief Financial Officer C/O SYNAVANT INC, 3445 PEACHTREE ROAD NE SUITE 1400, ATLANTA GA 30326
Adler Mark J Md director
Ian Banwell director P.O. BOX 34004, CHARLOTTE NC 28234
Shahir Kassam-adams director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Adam H Dublin director, officer: Chief Strategy Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Daniel J Barton director, officer: Chief Executive Officer 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940
Alyssa F Varadhan director 41 UNIVERSITY PLACE, SUITE 400, NEWTOWN PA 18940